Amit Srivastava Email

VP - RNA Therapeutics Portfolio Enhancement . Orbital Therapeutics

Current Roles

Employees:
67
Revenue:
$5.2M
About
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previously possible. We’re building a first-in-kind platform designed to sit at the intersection of RNA technology delivery methods, data science and automation to develop an expansive portfolio of medicines, initially focused in the areas of vaccines, immunomodulation, protein replacement and regenerative medicine. \n\nFounded by experts in the fields of genetic medicine and RNA development and delivery, we have a dynamic operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers and business leaders.
Orbital Therapeutics Address
21 Erie Street
null, null
Orbital Therapeutics Email

Past Companies

Orbital TherapeuticsVice President - RNA Therapeutics Portfolio Enhancement
PfizerLead - COVID-19 & mRNA vaccines Scientific & Medical Affairs | LatAm, AfME, Asia + China
PfizerLead - COVID-19 & Meningococcal vaccines Scientific & Medical Affairs | LatAm, AfME, Asia + China

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.